Affiliation:
1. Biochemistry Laboratory, Department of Pharmacy, University of Genoa, 16132 Genova, Italy
2. Department of Experimental Medicine, University of Genoa, 16132 Genova, Italy
Abstract
Hypercortisolism is known to affect platelet function. However, few studies have approached the effect of exogenous cortisol on human platelets, and the results obtained are conflicting and unconvincing. In this study, the effect of exogenous cortisol on several parameters indicative of oxidative status in human platelets has been analysed. We have found that cortisol stimulates ROS production, superoxide anion formation, and lipid peroxidation, with these parameters being in strict correlation. In addition, cortisol decreases GSH and membrane SH-group content, evidencing that the hormone potentiates oxidative stress, depleting platelet antioxidant defence. The involvement of src, syk, PI3K, and AKT enzymes in oxidative mechanisms induced by cortisol is shown. The main sources of ROS in cells can include uncontrolled increase of NADPH oxidase activity and uncoupled aerobic respiration during oxidative phosphorylation. Both mechanisms seem to be involved in ROS formation induced by cortisol, as the NADPH oxidase 1 inhibitor 2(trifluoromethyl)phenothiazine, and rotenone and antimycin A, complex I and III inhibitor, respectively, significantly reduce oxidative stress. On the contrary, the NADPH oxidase inhibitor gp91ds-tat, malate and NaCN, complex II and IV inhibitor, respectively, have a minor effect. It is likely that, in human platelets, oxidative stress induced by cortisol can be associated with venous and arterial thrombosis, greatly contributing to cardiovascular diseases.
Reference67 articles.
1. Long-Term Side Effects of Glucocorticoids;Oray;Expert Opin. Drug Saf.,2016
2. Disorders of Hemostasis in Overt and Subclinical Hypercortisolism;Sworczak;Exp. Clin. Endocrinol. Diabetes,2013
3. Assessment of Platelet Function in Endogenous Hypercortisolism;Mital;Endokrynol. Pol.,2015
4. Hypercortisolism and Hemostasis;Sworczak;Pol. Merkur. Lek.,2009
5. Mandadi, S., Pulluru, H., and Annie, F. (2022). Comparative Outcomes of Combined Corticosteroid and Remdesivir Therapy with Corticosteroid Monotherapy in Ventilated COVID-19 Patients. PLoS ONE, 17.